TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33027267

Group type: EXPERIMENTAL
Intervention: One-to-one health education and educational brochures about cervical cancer and cervical cancer screening.
Number of subjects: 2140

Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 2140

Group type: EXPERIMENTAL
Intervention: One-to-one health education and educational brochures.
Number of subjects: 2140

Group type: EXPERIMENTAL
Intervention: Educational status of the first degree.
Number of subjects: 2140

Group type: EXPERIMENTAL
Intervention: History of sexually transmitted infections (STIs).
Number of subjects: 2140
Study: 35367978

Group type: EXPERIMENTAL
Intervention: Group A (carbon‐fiber support board and hollowed‐out cervicothoracic thermoplastic mask)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Group B (only carbon‐fiber support board)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Group A
Number of subjects: 40

Group type: COMPARATOR
Intervention: Group B
Number of subjects: 40
Study: 32370818

Group type: EXPERIMENTAL
Intervention: escitalopram 10 mg/tab daily
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: moclobemide 150 mg/tab daily
Number of subjects: 111

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: escitalopram and moclobemide
Number of subjects: 111
Study: 34473848

Group type: EXPERIMENTAL
Intervention: Training toward initial theoretical optimal FV-profile
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Training away from initial theoretical optimal FV-profile
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Training irrespective of initial theoretical optimal FV-profile
Number of subjects: 40
Study: 32316129

Group type: EXPERIMENTAL
Intervention: Passiflora setacea juice (250 mL)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PB)
Number of subjects: 12
Study: 36241898

Group type: EXPERIMENTAL
Intervention: Low-volume high-intensity interval training (HIIT), 12 weeks, 3 times weekly on a rowing ergometer, average power output of 138 W
Number of subjects: 142

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Low-volume high-intensity interval training (HIIT)
Number of subjects: 142
Study: 33527578

Group type: EXPERIMENTAL
Intervention: Virtual support using smartglass technology during TAVR proctoring
Number of subjects: 2
Study: 32807632

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) with aerobic exercise plus usual care (UC)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 187
Study: 35233923

Group type: EXPERIMENTAL
Intervention: Metabolic surgery (Roux-en-Y gastric bypass, adjustable gastric band, or sleeve gastrectomy)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Medical/lifestyle intervention
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Metabolic surgery
Number of subjects: 302
Study: 32095843

Group type: EXPERIMENTAL
Intervention: Prilocaine
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Prilocaine + Tramadol 1 mg/kg (P + T1)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Prilocaine + Tramadol 2 mg/kg (P + T2)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Normal saline solution (Control group)
Number of subjects: 117
Study: 35285803

Group type: EXPERIMENTAL
Intervention: BP-PtCr-EES with 4 months DAPT
Number of subjects: 818

Group type: COMPARATOR
Intervention: DP-CoCr-EES with 12 months DAPT
Number of subjects: 818
Study: 32015256

Group type: EXPERIMENTAL
Intervention: iHEART intervention (smartphone-based electrocardiogram monitoring and motivational text messages)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 238
Study: 35473345

Group type: EXPERIMENTAL
Intervention: Ginger-indirect moxibustion plus acupuncture
Number of subjects: 290

Group type: COMPARATOR
Intervention: Acupuncture alone
Number of subjects: 290
Study: 34554649

Group type: EXPERIMENTAL
Intervention: Home-based aerobic exercise at 40-60% peak heart rate thrice weekly and resistance training at 70% of one-repetition maximum twice weekly for 6 months
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Home-based aerobic exercise and resistance training
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no specific intervention)
Number of subjects: 46
Study: 35603664

Group type: EXPERIMENTAL
Intervention: Finger millet muffin
Number of subjects: 29

Group type: COMPARATOR
Intervention: Wheat muffin
Number of subjects: 29
Study: 33683782

Group type: EXPERIMENTAL
Intervention: 2% deoxyarbutin
Number of subjects: 59

Group type: COMPARATOR
Intervention: 4% hydroquinone
Number of subjects: 59
Study: 36138535

Group type: EXPERIMENTAL
Intervention: Early administration of TXA (2 g bolus within 45 minutes of injury)
Number of subjects: 649

Group type: COMPARATOR
Intervention: Late administration of TXA (1 g bolus plus 1 g 8 h infusion after 45 minutes of injury)
Number of subjects: 649
Study: 33277160

Group type: EXPERIMENTAL
Intervention: Customized surgical guide with fixation plates (splintless group)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Intermediate CAD/CAM splint (splint group)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Overall conclusion
Number of subjects: 16
Study: 33566212

Group type: EXPERIMENTAL
Intervention: COVID-19 prevention recommendations
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: HIV care visits
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Trust in information sources
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Telehealth access
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Knowledge from HIV pandemic
Number of subjects: 96
Study: 32622781

Group type: EXPERIMENTAL
Intervention: cGAN
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: cycleGAN
Number of subjects: 173
Study: 35253077

Group type: EXPERIMENTAL
Intervention: Low-intensity antenatal primary care intervention focusing on diet and physical activity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Maternal BMI at enrollment
Number of subjects: 0
Study: 32457012

Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg intravenous)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 36231604

Group type: EXPERIMENTAL
Intervention: Neurorehabilitation treatment plus ultrasound-guided dry needling
Number of subjects: 20

Group type: COMPARATOR
Intervention: Neurorehabilitation treatment
Number of subjects: 20
Study: 33961812

Group type: EXPERIMENTAL
Intervention: Sit-to-stand exercises and protein-rich nutritional supplements (12-week intervention)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Sit-to-stand exercises and protein-rich nutritional supplements
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Sit-to-stand exercises
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Combined intervention (nutrition and exercise)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 101
Study: 32183783

Group type: EXPERIMENTAL
Intervention: Adolescent Girls Empowerment Program (AGEP)
Number of subjects: 4661

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 4661
Study: 33434704

Group type: EXPERIMENTAL
Intervention: MIND diet with mild caloric restriction
Number of subjects: 604

Group type: COMPARATOR
Intervention: Usual diet with mild caloric restriction
Number of subjects: 604
Study: 36350478

Group type: EXPERIMENTAL
Intervention: HRVB
Number of subjects: 64

Group type: COMPARATOR
Intervention: RT
Number of subjects: 64
Study: 33606577

Group type: EXPERIMENTAL
Intervention: Adjuvanted recombinant zoster vaccine (RZV)
Number of subjects: 2729

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2729
Study: 32460618

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) therapy using low energy, nonionizing light primarily in the visible or near-infrared spectrum.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified in the abstract.
Number of subjects: 0
Study: 35228279

Group type: EXPERIMENTAL
Intervention: Neurofenix platform for home‐based rehabilitation of the upper limb
Number of subjects: 30
Study: 32205155

Group type: EXPERIMENTAL
Intervention: Targeted temperature management (TTM) at 33 °C
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normothermia and early treatment of fever (≥37.8 °C)
Number of subjects: 0
Study: 35177194

Group type: EXPERIMENTAL
Intervention: Clinical and stress testing parameters
Number of subjects: 5146

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 5146

Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 5146

Group type: EXPERIMENTAL
Intervention: Absence of prior myocardial infarction
Number of subjects: 5146

Group type: EXPERIMENTAL
Intervention: Transient ischemic dilation of the left ventricle on stress echocardiography
Number of subjects: 5146

Group type: EXPERIMENTAL
Intervention: Magnitude of ST-segment depression on ETT
Number of subjects: 5146

Group type: EXPERIMENTAL
Intervention: Peak metabolic equivalents achieved on ETT
Number of subjects: 5146
Study: 34304264

Group type: EXPERIMENTAL
Intervention: CCB transitional care programme (comprehensive geriatric assessment-based integrated care plan, face-to-face handover with community nurse, follow-up home visits, home-based cardiac rehabilitation)
Number of subjects: 306

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 306
Study: 35180099

Group type: EXPERIMENTAL
Intervention: Graston Technique (GT) combined with Conventional Physical Therapy (CPT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional Physical Therapy (CPT)
Number of subjects: 30
Study: 36161973

Group type: EXPERIMENTAL
Intervention: iBDecide (n=14)
Number of subjects: 35
Study: 35419831

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy with S‐1 (CCRT)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Radiotherapy alone (RT)
Number of subjects: 157
Study: 32139204

Group type: COMPARATOR
Intervention: IV chlorpheniramine (CPM)
Number of subjects: 75

Group type: COMPARATOR
Intervention: IV chlorpheniramine (CPM) and IV dexamethasone (CPM/Dex)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: IV chlorpheniramine (CPM), IV dexamethasone (CPM/Dex), and oral prednisolone for 5 days (CPM/Dex/Pred)
Number of subjects: 75
Study: 32871535

Group type: EXPERIMENTAL
Intervention: Pimavanserin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36065850

Group type: EXPERIMENTAL
Intervention: Functional Training (FT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Core Stabilization Training (CT)
Number of subjects: 18
Study: 32349359

Group type: EXPERIMENTAL
Intervention: Reasoning and Rehabilitation V2 (R&R2) programme
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 142
Study: 33450430

Group type: EXPERIMENTAL
Intervention: Team handball group (THG, n = 41)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (CG, n = 26)
Number of subjects: 67
Study: 34018371

Group type: EXPERIMENTAL
Intervention: IC‐ECG guidance combined with conventional anatomical landmark guidance (n=105)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Conventional anatomical landmark guidance (n=105)
Number of subjects: 210
Study: 36281627

Group type: EXPERIMENTAL
Intervention: Mexiletine (333 mg oral dose)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 33248918

Group type: EXPERIMENTAL
Intervention: Intraarterial BMSC injection (group B)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Sham injection (group A)
Number of subjects: 81
Study: 34982354

Group type: EXPERIMENTAL
Intervention: Patient-reported anchors
Number of subjects: 154
Study: 33026658

Group type: EXPERIMENTAL
Intervention: BMT‐CARE
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study: 35912647

Group type: EXPERIMENTAL
Intervention: 1-month DAPT followed by clopidogrel monotherapy
Number of subjects: 5997

Group type: COMPARATOR
Intervention: 12-month DAPT with aspirin and clopidogrel
Number of subjects: 5997
Study: 34339469

Group type: EXPERIMENTAL
Intervention: ACEI/ARB
Number of subjects: 17849

Group type: EXPERIMENTAL
Intervention: BB
Number of subjects: 17849
Study: 32486595

Group type: EXPERIMENTAL
Intervention: Spectral CT-based radiomics
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: CT-reported LN status
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Radiomics signatures (40 keV-arterial phase, 65 keV-venous phase, IC-VP of tumor, CT-reported LN status)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Radiomics nomogram
Number of subjects: 196
Study: 36456477

Group type: EXPERIMENTAL
Intervention: Cervical injection group (1 ml of nano-carbon injected at 3 and 9 o'clock in the cervix)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Uterine injection group (4 ml of methylene blue injected into the uterine body at 2 sites)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Combined injection group (1 ml of nano-carbon + 4 ml of methylene blue)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Overall results for all patients
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Low-risk patients
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Medium-high risk patients
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Pathological super-staging results
Number of subjects: 73
Study: 34237608

Group type: EXPERIMENTAL
Intervention: Differentially expressed circRNAs in testes and ovaries, including 541 upregulated and 169 downregulated circRNAs in testes.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Five DE circRNAs selected for quantitative real-time PCR analysis.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Predicted interactions between circRNAs and miRNAs.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Constructed ceRNA networks.
Number of subjects: 0
Study: 35024154

Group type: EXPERIMENTAL
Intervention: Perioperative hypotension-avoidance strategy
Number of subjects: 6800

Group type: COMPARATOR
Intervention: Hypertension-avoidance strategy (Control)
Number of subjects: 6800
Study: 32682370

Group type: EXPERIMENTAL
Intervention: Tremelimumab (anti-CTLA-4 antibody)
Number of subjects: 0
Study: 34366134

Group type: EXPERIMENTAL
Intervention: Self-facilitated discussion groups over 6 months
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 125
Study: 34709010

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (loading dose 1 µg/kg and maintenance dose 0.25 µg/kg/h)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (loading dose 1 µg/kg and maintenance dose 0.5 µg/kg/h)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline solution (Control)
Number of subjects: 0
Study: 34157981

Group type: EXPERIMENTAL
Intervention: OPTICA trial participants
Number of subjects: 323

Group type: COMPARATOR
Intervention: FIRE database patients
Number of subjects: 323
Study: 36429418

Group type: EXPERIMENTAL
Intervention: Standard cardiac rehabilitation (CR) with breathing exercises (BE) including inspiratory muscle training (IMT) and breathing calisthenics (BC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard cardiac rehabilitation (CR) alone
Number of subjects: 40
Study: 33836311

Group type: COMPARATOR
Intervention: Traditional Advance Directive (AD)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Letter Advance Directive (AD)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Traditional AD and Letter AD
Number of subjects: 126
Study: 32900389

Group type: EXPERIMENTAL
Intervention: Tooth-borne rapid maxillary expansion (TB-RME)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Bone-borne rapid maxillary expansion (BB-RME)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison between TB-RME and BB-RME
Number of subjects: 40
Study: 35260255

Group type: EXPERIMENTAL
Intervention: Selective laser melting (SLM) frameworks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Traditional frameworks
Number of subjects: 29
Study: 36028279

Group type: EXPERIMENTAL
Intervention: Cytisine (25‐day course)
Number of subjects: 2472

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2472
Study: 33006501

Group type: EXPERIMENTAL
Intervention: Post-placental IUD insertion
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Puerperal IUD insertion
Number of subjects: 1000
Study: 33411391

Group type: EXPERIMENTAL
Intervention: Caregiver training intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 33039658

Group type: EXPERIMENTAL
Intervention: Enk™
Number of subjects: 160

Group type: COMPARATOR
Intervention: Manujet™
Number of subjects: 160
Study: 35728675

Group type: EXPERIMENTAL
Intervention: Genetic counselling (GC)
Number of subjects: 420

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 420
Study: 33608212

Group type: COMPARATOR
Intervention: Checkpoint inhibitor (CPI) immunotherapy alone (n = 19)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: CPI immunotherapy in combination with 4 cycles doublet carboplatin/pemetrexed chemotherapy and 3 to 5 fractions SBRT (n = 16)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Subsequent course of SBRT based on response (n = 15)
Number of subjects: 35
Study: 33998099

Group type: EXPERIMENTAL
Intervention: Aspirin (150 mg/day)
Number of subjects: 1592

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1592
Study: 33106028

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection (single injection, with or without ultrasound guidance)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Second corticosteroid injection
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Surgical excision
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection (across all groups)
Number of subjects: 36
Study: 32379134

Group type: EXPERIMENTAL
Intervention: Intramedullary nailing (IMN)
Number of subjects: 267

Group type: COMPARATOR
Intervention: External fixation
Number of subjects: 267
Study: 35629015

Group type: EXPERIMENTAL
Intervention: Low-intensity PE (0.3 mA, 90 s)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: High-intensity PE (three pulses of 3 mA, 3 s)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sham (without electrical current)
Number of subjects: 54
Study: 36317442

Group type: EXPERIMENTAL
Intervention: Quercetin 500 mg daily for 40 days
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 33113567

Group type: EXPERIMENTAL
Intervention: Prasugrel (3.75 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clopidogrel (75 mg/day)
Number of subjects: 0
Study: 32203739

Group type: EXPERIMENTAL
Intervention: Occupational Connections (OC) group intervention
Number of subjects: 33

Group type: COMPARATOR
Intervention: Open leisure activity group (control condition)
Number of subjects: 33
Study: 616649627

Group type: EXPERIMENTAL
Intervention: Approach-Avoidance Task (AAT) - lock condition
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Approach-Avoidance Task (AAT) - standard condition
Number of subjects: 101

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 101
Study: 35088720

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo pills
Number of subjects: 0
Study: 32046865

Group type: EXPERIMENTAL
Intervention: Serum PTH levels < 2.9 pmol/L measured 1 hour after surgery and on the first postoperative day
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Presence of hypocalcemia on the first and fifth postoperative day
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Higher doses of calcium supplements
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: ROC curve analysis of PTH levels
Number of subjects: 143
Study: 36235798

Group type: EXPERIMENTAL
Intervention: Two gold kiwifruit (2/day)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Psyllium (fiber‐matched, 7.5 g/day)
Number of subjects: 56
Study: 32588160

Group type: EXPERIMENTAL
Intervention: Correlation plots of ionic ratio (Na+/Cl‐) versus ionic concentration (Cl‐)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomization process for detecting spurious correlation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Qualitative and quantitative tools for detecting induced correlation
Number of subjects: 0
Study: 32736141

Group type: EXPERIMENTAL
Intervention: 10 % citric acid (CA10) for 90 seconds
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 50 % citric acid (CA50) for 90 seconds
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 50 % citric acid (CA50) for 180 seconds
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (C) rinsing with saline solution for 90 seconds
Number of subjects: 32
Study: 36062819

Group type: EXPERIMENTAL
Intervention: Early computed tomography coronary angiography
Number of subjects: 1748

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1748
Study: 34580096

Group type: EXPERIMENTAL
Intervention: Temocillin (2 g three times a day)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Carbapenem (meropenem 1 g three times a day or ertapenem 1 g once daily)
Number of subjects: 334
Study: 34325676

Group type: EXPERIMENTAL
Intervention: DVD-delivered physical activity program (FlexToBa™; n = 22)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Attentional control condition (n = 24)
Number of subjects: 46
Study: 32747013

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus sorafenib (bevacizumab 5 mg/kg IV every 2 weeks, sorafenib 200 mg bid 5 days-on/2 days-off)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus sorafenib
Number of subjects: 54
Study: 34655547

Group type: COMPARATOR
Intervention: 0.5% timolol eye drops administered twice daily
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Selective laser trabeculoplasty (SLT)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Adverse events
Number of subjects: 201
Study: 32210440

Group type: EXPERIMENTAL
Intervention: TGF‐?RI/ALK5 inhibitor galunisertib
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: AFP responders (21% of patients in Part A with decrease of >20% from baseline)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: TGF‐?1 responders (51% of all patients)
Number of subjects: 149
Study: 33219421

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 11

Group type: COMPARATOR
Intervention: Active rTMS and Sham group
Number of subjects: 11